Taiwan NHI to Cover Costly Gene Therapy for Rare Disease
Taipei: Taiwan’s National Health Insurance Administration (NHIA) announced Thursday that gene therapy for the rare genetic disorder aromatic l-amino acid decarboxylase (AADC) deficiency will be covered under the National Health Insurance (NHI) program…
